Certara logo

Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include 2,000 biopharmaceutical companies, academic institutions, and regulatory agencies across 62 countries.

Certara
Pharma Intelligence UK Ltd

Conducting Clinical Trials in the Parallel Virtual Universe

Capture new insights into accelerating and streamlining processes at every stage of clinical research. Don’t miss this illuminating article from Certara. Read now for insights into:
Article Clinical Studies Pharmaceutical Research and Development
Certara
Pharma Intelligence UK Ltd

Clinical Pharmacology & Model-Informed Drug Development Insights for Targeted Radiation Therapies (TRT)

Don’t miss insights from a recent recorded panel discussion among the subject matter area experts at Certara. Watch on demand to:
On-Demand Webinar Clinical Studies Pharmaceutical Research and Development
Certara
Pharma Intelligence UK Ltd

Why are Clinical Data Standards Essential for EDC and Non-EDC Data?

Read the blog now to explore:
Blog Clinical Studies Pharmaceutical Research and Development
Certara
Pharma Intelligence UK Ltd

Higher Standards: Achieving Cleaner Data, Faster, from Protocol to Submission

Discover the importance of pre-submission validation, plus insights into accelerating the generation of define.xml files and Reviewer’s Guides. Watch now to explore:
On-Demand Webinar Clinical Studies Pharmaceutical Research and Development
Certara
Pharma Intelligence UK Ltd

Waiving Clinical Studies and Accelerating Drug Development for Kinase Inhibitor (KI) Drugs

Explore how Simcyp delivered benefits during multiple stages of the drug cycle, with these information-rich case studies from Certara. Read now for insights into:
Case Study Clinical Studies Pharmaceutical Research and Development
Certara
Pharma Intelligence UK Ltd

Understanding Europe’s New Clinical Trial Regulations

Learn more about the purpose of EU-CTR and uncover best practices for adapting to its requirements, with insights from the experts at Certara. You will gain a deeper understanding of these regulations and the requirements of using its CTIS to submit, assess, authorize, supervise, and report on clinical trials in the EU. Read now to:
Whitepaper Clinical Studies Pharmaceutical Research and Development